Meitheal Gets US Enoxaparin Approval

NKF-Controlled Meitheal Makes Progress With Lovenox Rival

12 Dec 2019

• By Akriti Seth

Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.

Syringe — Meitheal Has Received FDA Approval For Enoxaparin • Source: Shutterstock

Injectables specialist Meitheal Pharmaceuticals has received US Food and Drug Administration approval for its generic version of Lovenox (enoxaparin).

Meitheal is licensing enoxaparin through its partnership with China’s Nanjing King-Friend Biochemical Pharmaceutical, which earlier this year paid $95m to...